Changeflow GovPing Healthcare & Life Sciences Aligned Medical Solutions Early Alert: Angio Pa...
Urgent Enforcement Amended Final

Aligned Medical Solutions Early Alert: Angio Pack Convenience Kit Recall Due to Namic RA Syringe Failure

Favicon for www.fda.gov FDA Medical Device Recalls
Filed
Detected
Email

Summary

The FDA issued an Early Alert on April 23, 2026, advising that Aligned Medical Solutions recalled Angio Pack convenience kits (AMS6908E, AMS6908F) containing Medline Namic RA Syringes, after Medline recalled those syringes due to a rotating adaptor that may unwind during use, causing loose or disconnected syringe-to-manifold connections. Four serious injuries and no deaths have been reported as of March 13, 2026. Affected parties are instructed to identify, quarantine, and apply warning labels to affected kits, and to remove and discard the affected syringes.

Published by FDA on fda.gov . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

About this source

GovPing monitors FDA Medical Device Recalls for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 17 changes logged to date.

What changed

Aligned Medical Solutions issued an urgent recall notification for convenience kits containing Medline Namic Angiographic Control Syringes with Rotating Adaptor (RA Syringes), after Medline identified that the syringe rotating adaptor on affected devices may unwind during use, resulting in a loose connection or full disconnection between the syringe and manifold. The failure may introduce air into the line, causing air embolism, and presents potential for biohazard exposure, blood loss, and infection. Four serious injuries have been reported as of March 13, 2026. Affected parties must identify and quarantine affected product, apply over-labels with warning language provided by the firm, and remove and destroy the affected Namic RA Syringes. If use is unavoidable to prevent patient harm, the syringe must be used with extreme caution including manual stabilization and continuous monitoring throughout the procedure.

What to do next

  1. Identify, segregate, and quarantine all affected product.
  2. Add warning labels to all affected kits stating that the affected syringes must be removed and discarded from further use.
  3. Per Medline, due to the risk of serious injury or death, customers are directed to remove and destroy all Namic RA Syringes.

Archived snapshot

Apr 23, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.


CDRH is issuing this Early Alert **to notify the public of a potentially high-risk device issue.* The FDA will keep the public informed and update this web page as significant new information becomes available.*

Affected Product

The FDA is aware that Aligned Medical Solutions has issued a letter to affected customers recommending certain angiographic syringes included in convenience kits be removed from where they are used or sold. Affected components:

  • Medline Device Description: Syringe 10ML Angio W/RA
  • Medline Part Number: 80085007
  • AMS Device Description: Syringe 10CC Control Polycarb w/ ROT Adapter
  • AMS Part Number: 39331
  • Lot Number: 70209, 71257, 72311, 75764, 77812, 80915, 86214, 94136, 102993, 108049, 123896, 127096, 135426, 140436, 189197 Affected Kits:
Pack Number Pack Name Lot Numbers UDI-DI
AMS6908E Angio Pack 214875 B098AMS6908E0
AMS6908F Angio Pack 215436

225001
226706
234088 | B098AMS6908F0 |

What to Do

Identify kits with affected syringes. Apply over-labels to all affected kits on hand stating that the affected syringes must be removed and discarded from further use.

On April 1, Aligned Medical Solutions sent all affected customers a letter recommending the following actions:

  • Identify, segregate, and quarantine all affected product.
  • Add warning labels to all affected kits stating that the affected syringes must be removed and discarded from further use.
    • Use the labeling template provided by Aligned Medical Solutions to print labels. This label should be applied in a prominently visible location to end-users. The location chosen should not cover any other critical product information found on existing product labeling.
  • If you are a distributor or have resold or transferred this product, notify them of this recall communication.
  • Per Medline, due to the risk of serious injury or death, customers are directed to remove and destroy all Namic RA Syringes. If use is unavoidable because failure to proceed would result in patient harm, the Namic RA syringe must be used with extreme caution and vigilance, including manual stabilization of syringe-to-manifold connections and continuous, 100% monitoring during setup and throughout the entire procedure.
  • All usage guidelines and the Instructions for Use are provided in Medline’s recall letter. Strict adherence to all usage guidelines and the Instructions for Use are required. Check this web page for updates. The FDA is currently reviewing information about this potentially high-risk device issue and will keep the public informed as significant new information becomes available.

Reason for Alert

Aligned Medical Solutions initiated an urgent Medical Device Recall notification for convenience kits that contain syringes affected by Medline’s Namic Angiographic Control Syringes with Rotating Adaptor (“Namic RA Syringes”) recall.

Medline Industries stated that the syringe rotating adaptor on affected devices may unwind during use, resulting in a loose connection or full disconnection between the syringe and manifold. If unwinding occurs, there is potential for biohazard exposure, blood loss, and infection. Loose connections or disconnections may introduce air into the line, which could result in air embolism. These conditions may lead to serious injury or death. All units have the potential to exhibit this failure mode.

As of March 13, Medline Industries has reported four serious injuries and no deaths associated with this issue.

Device Use

Convenience kits contain various surgical instruments, dressings and/or other materials, and pharmaceutical components that are intended to be used during various surgical procedures.

Contact Information

Customers in the U.S. with adverse reactions, quality problems, or questions about this recall should contact Aligned Medical Solutions at fieldcorrectiveaction@alignedmedicalsolutions.com.

Additional FDA Resources

  1. Angiographic Syringe Recall: Medline Industries Removes Namic Angiographic Rotating Adaptor Control Syringes [04/09/2026]
  2. FDA Enforcement Report for Medline Namic RA Syringes Recall
  3. CDRH Medical Device Recall Database for Medline Namic RA Syringes Recall

Unique Device Identifier (UDI)

The unique device identifier (UDI) helps identify individual medical devices sold in the United States from manufacturing through distribution to patient use. The UDI allows for more accurate reporting, reviewing, and analyzing of adverse event reports so that devices can be identified, and problems potentially corrected more quickly.

How do I report a problem?

Health care professionals and consumers may report adverse reactions or quality problems they experienced using these devices to MedWatch: The FDA Safety Information and Adverse Event Reporting Program.

  • ## Content current as of:

04/23/2026

  • Regulated Product(s)

    • Medical Devices

Get daily alerts for FDA Medical Device Recalls

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from FDA.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
FDA
Filed
April 23rd, 2026
Instrument
Enforcement
Branch
Executive
Legal weight
Binding
Stage
Final
Change scope
Substantive

Who this affects

Applies to
Medical device makers Healthcare providers
Industry sector
3345 Medical Device Manufacturing
Activity scope
Medical device recall response Product safety notification Distributor notification
Geographic scope
United States US

Taxonomy

Primary area
Medical Devices
Operational domain
Clinical Operations
Compliance frameworks
GxP
Topics
Public Health Product Safety

Get alerts for this source

We'll email you when FDA Medical Device Recalls publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!